Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 210-216 , September 2008

Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy

  • Manuel Ascencio

      Affiliations

    • Department of Gynaecology and Obstetrics, Lille University Hospital, 59037 Lille Cedex, France
    • INSERM (French National Institute of Health and Medical Research) – U703, Pavillon Vancostenobel, Lille University Hospital, 59037 Lille Cedex, France
    • ,
  • Juan Pablo Estevez

      Affiliations

    • Department of Gynaecology and Obstetrics, Lille University Hospital, 59037 Lille Cedex, France
    • INSERM (French National Institute of Health and Medical Research) – U703, Pavillon Vancostenobel, Lille University Hospital, 59037 Lille Cedex, France
    • ,
  • Marie Delemer

      Affiliations

    • Department of Gynaecology and Obstetrics, Lille University Hospital, 59037 Lille Cedex, France
    • ,
  • Marie Odile Farine

      Affiliations

    • Department of Anatomo-pathology, Lille University Hospital, 59037 Lille Cedex, France
    • ,
  • Pierre Collinet

      Affiliations

    • Department of Gynaecology and Obstetrics, Lille University Hospital, 59037 Lille Cedex, France
    • ,
  • Serge Mordon, PhD

      Affiliations

    • INSERM (French National Institute of Health and Medical Research) – U703, Pavillon Vancostenobel, Lille University Hospital, 59037 Lille Cedex, France
    • Corresponding Author InformationCorresponding author.

References 

  1. Benedet JL, Bender H, Jones H, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70(2):209–262
  2. Rensontet A, Velten M, Jougla E, et al. Evolution de l’incidence et de la mortalité par cancer en france de 1978 à 2000. Actis-Paris. 2003;119–124
  3. Eisenkop SM, Nalick RH, Wang HJ, et al. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol. 1993;51(2):224–229
  4. McCarron PA, Donnelly RF, Zawislak A, et al. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm. 2005;293(1–2):11–23
  5. McCarron PA, Ma LW, Juzenas P, et al. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J Environ Pathol Toxicol Oncol. 2006;25(1–2):389–402
  6. Saah-Briffaut E, Collinet P, Saah R, et al. Treatment of squamous intraepithelial lesion of type CIN2 et CIN3 with laser CO2 vaporization: retrospective study of 52 cases. J Gynecol Obstet Biol Reprod (Paris). 2006;35(8 Pt 1):785–789
  7. Yamaguchi S, Tsuda H, Takemori M, et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology. 2005;69(2):110–116
  8. Hillemanns P, Wang X, Staehle S, et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100(2):271–275
  9. Zaak D, Sroka R, Stocker S, et al. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX—in vivo experiments on the dunning rat tumor model. Urol Int. 2004;72(3):196–202
  10. El Khatib S, Didelon J, Leroux A, et al. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol. 2004;172(5 Pt 1):2013–2017
  11. Gossner L, Sroka R, Hahn EG, et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc. 1995;41(1):55–58
  12. Pech O, Gossner L, May A, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc. 2005;62(1):24–30
  13. Regula J, Ravi B, Bedwell J, et al. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer—prolonged animal survival. Br J Cancer. 1994;70(2):248–254
  14. Ziolkowski P, Osiecka BJ, Oremek G, et al. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol. 2004;4(2):121–129
  15. Betz CS, Lai JP, Xiang W, Janda P, et al. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci. 2002;1(5):315–319
  16. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
  17. Loning MC, Diddens HC, Holl-Ulrich K, et al. Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: fluorescence microscopy studies. Lasers Surg Med. 2006;38(June (5)):549–554
  18. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6(1–2):143–148
  19. Meijinders P, Star W, De Bruijn R. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolevulinic acid. Lasers. 1996;11:121–131
  20. Lopez RF, Lange N, Guy R, et al. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev. 2004;56(1):77–94
  21. Wyld L, Burn JL, Reed MW, et al. Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer. 1997;76(6):705–712
  22. Leibovici L, Schoenfeld N, Yehoshua HA, et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer. 1988;62(11):2297–2300
  23. el-Sharabasy MM, el-Waseef AM, Hafez MM, et al. Porphyrin metabolism in some malignant diseases. Br J Cancer. 1992;65(3):409–412
  24. Brunner H, Hausmann F, Knuechel R. New 5-aminolevulinic acid esters—efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol. 2003;78(5):481–486
  25. Lange N, Jichlinski P, Zellweger M, et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer. 1999;80(1–2):185–193
  26. Jouve E, Collinet P, Delemer-Lefebvre M, et al. Alternative administrations of hexaminolevulinate (HeALA) for laparoscopic fluorescence diagnosis of metastatic ovarian cancer in a rat model. In: 15th annual congress of the european society for gynaecological endoscopy; 2006; Strasbourg: Medimond International Proceedings; 2006.
  27. Regis C, Collinet P, Farine MO, et al. Comparison of aminolevulinic acid- and hexylester aminolevulinate-induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model. Photomed Laser Surg. 2007;25(4):304–311
  28. Hua Z, Gibson SL, Foster TH, et al. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res. 1995;55(8):1723–1731
  29. Messmann H, Mlkvy P, Buonaccorsi G, et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer. 1995;72(3):589–594
  30. Pogue BW, Hasan T. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat Res. 1997;147(5):551–559
  31. Rose GS, Tocco LM, Granger GA, et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol. 1996;175(3 Pt 1):593–599
  32. Ascencio M, Delemer-Lefebvre M, Farine MO, et al. Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model. Photodiag Photodyn Ther. 2007;4(4):254–260
  33. Foster TH, Murant RS, Bryant RG, et al. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res. 1991;126(3):296–303
  34. Hornung R, Fink D, Dobler-Girdziunaite D, et al. Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model. Gynecol Oncol. 1999;75(3):447–452
  35. Major AL, Rose GS, Svaasand LO, et al. Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study. J Photochem Photobiol B. 2002;66(2):107–114
  36. Fotinos N, Campo MA, Popowycz F, et al. 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol. 2006;82(4):994–1015
  37. Marti A, Jichlinski P, Lange N, et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol. 2003;170(2 Pt 1):428–432
  38. Ludicke F, Gabrecht T, Lange N, et al. Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study. Br J Cancer. 2003;88(11):1780–1784
  39. Dougherty TJ. Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol. 1984;2(2):83–116
  40. McCaughan JS, Hicks W, Laufman L, et al. Palliation of esophageal malignancy with photoradiation therapy. Cancer. 1984;54(12):2905–2910
  41. Grosjean P, Wagnieres G, Fontolliet C, et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514nm compared with 630nm light irradiation after sensitization with Photofrin II. Br J Cancer. 1998;77(11):1989–1995
  42. Etienne J, Dorme N, Bourg-Heckly G, et al. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc. 2004;59(7):880–889
  43. van den Boogert J, van Staveren HJ, de Bruin RW, et al. Fractionated illumination for oesophageal ALA–PDT: effect on blood flow and PpIX formation. Lasers Med Sci. 2001;16(1):16–25
  44. Boere IA, Robinson DJ, de Bruijn HS, et al. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett’s esophagus following 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol. 2006;82(6):1638–1644
  45. Mlkvy P, Messmann H, Pauer M, et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer. 1996;73(12):1473–1479
  46. Muller S, Walt H, Dobler-Girdziunaite D, et al. Enhanced photodynamic effects using fractionated laser light. J Photochem Photobiol B. 1998;42(1):67–70
  47. Pe MB, Ikeda H, Inokuchi T. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue. Eur J Cancer B: Oral Oncol. 1994;30B(3):174–178
  48. van der Veen N, van Leengoed HL, Star WM. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer. 1994;70(5):867–872
  49. Curnow A, McIlroy BW, Postle-Hacon MJ, et al. Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon. Photochem Photobiol. 1999;69(1):71–76
  50. Curnow A, MacRobert AJ, Bown SG. Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid. Lasers Surg Med. 2006;38(4):325–331
  51. Iinuma S, Schomacker KT, Wagnieres G, et al. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 1999;59(24):6164–6170
  52. Curnow A, Haller JC, Bown SG. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B. 2000;58(2–3):149–155
  53. Curnow A, Bown SG. The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid—a study on normal rat colon. Br J Cancer. 2002;86(6):989–992
  54. Dietel W, Pottier R, Pfister W, et al. 5-Aminolaevulinic acid (ALA) induced formation of different fluorescent porphyrins: a study of the biosynthesis of porphyrins by bacteria of the human digestive tract. J Photochem Photobiol B. 1997;86(1):77–86
  55. Juzeniene A, Juzenas P, Iani V, et al. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol. 2002;76(3):329–334

PII: S1572-1000(08)00080-X

doi: 10.1016/j.pdpdt.2008.09.004

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 210-216 , September 2008

Article Tools

* Image Usage & Resolution